96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-001678-17-NL
(EUCTR)
14/01/201614/01/2016A Pilot Study of FFP104 in Subjects with Crohn’s DiseaseA Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects with Moderate to Severely Active Crohn’s Disease Moderate to Severely Active Crohn’s disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20]Product Code: FFP104Fast Forward Pharmaceuticals, B.V.NULLNot RecruitingFemale: yes
Male: yes
24Phase 2Belgium;Netherlands
2NCT02465944
(ClinicalTrials.gov)
January 201618/5/2015A Pilot Study of FFP104 in Subjects With Crohn's DiseaseA Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects With Moderate to Severely Active Crohn's DiseaseCrohn's DiseaseDrug: FFP104;Drug: PlaceboFast Forward PharmaceuticalsNULLRecruiting18 Years75 YearsBoth24Phase 1;Phase 2Belgium;Netherlands
3EUCTR2015-001678-17-BE
(EUCTR)
01/12/201510/09/2015A Pilot Study of FFP104 in Subjects with Crohn’s DiseaseA Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects with Moderate to Severely Active Crohn’s Disease Moderate to Severely Active Crohn’s disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20]Product Code: FFP104Fast Forward Pharmaceuticals, B.V.NULLNot RecruitingFemale: yes
Male: yes
24Phase 2Belgium;Netherlands